Microsoft and OpenAI partnership deal with AWS and Google Cloud for OpenAI’s AI services expansion, showcasing tech collabora

Editorial illustration for Microsoft, OpenAI end pact; OpenAI can now sell on AWS and Google Cloud

Microsoft, OpenAI end pact; OpenAI can now sell on AWS...

Microsoft, OpenAI end pact; OpenAI can now sell on AWS and Google Cloud

By AI Daily Post Edited by Brian Petersen, Editor-in-Chief

May 3, 2026 • Updated: May 6, 2026 • 2 min read

Microsoft’s long‑standing cloud exclusivity with OpenAI is over. The two firms have untangled their partnership, opening the door for OpenAI’s models to run on Amazon Web Services and Google Cloud as well as Azure. While the move reshapes how developers will access the company’s AI tools, it also signals a broader shift in OpenAI’s financing strategy.

The split comes after months of speculation about the future of the Microsoft‑OpenAI relationship and follows a high‑profile funding announcement earlier this year. Investors have been watching closely, especially after a major tech retailer disclosed a multi‑billion‑dollar commitment that could influence the startup’s next steps. Here’s the thing: the scale of that capital injection matters for both the competitive dynamics of cloud providers and the roadmap OpenAI will follow.

In February, OpenAI announced that Amazon would invest up to $50 billion in the company — $15 billion upfront, with another $35 billion to foll

Unnecessary prescriptions allow bacteria to develop immunity, rendering life-saving medications ineffective. It means a dwindling list of treatment options for patients with serious infections. A 2024 report in The Lancet predicted that drug-resistant infections could cause 40 million deaths by 2050.

Traditional diagnostics to determine an antibiotic-resistant infection usually take two to three days, as they require culturing bacteria from a sample. But for some infections, such as sepsis, that is time patients don't have. For every hour of delayed treatment, the risk of death increases by between 4 to 9 percent.

While waiting for test results, doctors must use their best judgement in choosing which antibiotics to use. "AI-powered diagnostics are achieving accuracy above 99 percent without additional laboratory infrastructure," Darzi said. These types of rapid diagnostics are especially needed in rural and remote areas of the world, he added.

The World Health Organization estimates that antibiotic resistance is highest in southeast Asia and the eastern Mediterranean, where one in three reported infections were resistant in 2023. In Africa, one in five infections was resistant. AI could also help discover new drugs for resistant infections and predict the spread of resistant bacteria.

The UK's National Health Service is working with Google DeepMind to develop an AI system to combat antibiotic resistance.

Microsoft and OpenAI gut their exclusive deal, freeing OpenAI to sell on AWS and Google Cloud - VentureBeat AI

Why this matters

What does the new deal mean for the AI market? Microsoft and OpenAI have stripped away years of exclusivity, replacing it with a limited‑term framework that grants each party greater latitude to work with rivals. OpenAI can now pitch its models on Amazon Web Services and Google Cloud, broadening its customer base beyond Azure.

The shift also untethers revenue streams, ending the previous profit‑sharing model that tied the two firms together. Amazon’s pledged up to $50 billion investment—$15 billion now, with $35 billion contingent on future milestones—adds another variable to OpenAI’s financing picture. Yet the exact terms of the time‑limited arrangement remain unclear, as how quickly the new cloud partners will integrate OpenAI’s services.

Both companies have signaled confidence, but it's unclear whether the loosened ties will translate into sustained growth or simply redistribute existing business. Observers will watch how the expanded cloud access influences pricing, performance, and developer adoption in the months ahead.